Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04406714 · ClinicalTrials.gov registry record · NA
Scaling CRC Screening Through Outreach, Referral, and Engagement (SCORE)
A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 4,318
- Enrollment target
NCT04406714: Completed NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT04406714 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 4,318 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (208% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04406714, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,318 participants
- Enrollment target
Study Summary
This study will test the effectiveness of mailing fecal immunochemical tests (FITs) in increasing colorectal cancer (CRC) screening rates in U.S. adults ages 45-75. We are implementing this study in two age groups, 45-49 years and 50-75 years.
Primary Outcome
"The proportion of subjects who received study Intervention (Age Group 50-75) and did not receive study intervention (Usual Care - Age Group 50-75 who completed CRC screening using any of the screening modalities recommended by the United States Preventive Services Task Force per electronic health record review. Fecal immunochemical test (FIT), fecal occult blood test \[FOBT\], fecal immunochemical test - deoxyribonucleic acid (FIT-DNA), colonoscopy, flexible sigmoidoscopy, flexible sigmoidosco
Interventions
- BEHAVIORAL Trial Mailed FIT Intervention - Age Group 50-75
- BEHAVIORAL Sub-Study Mailed FIT Intervention Enhanced Envelope - Age Group 45-49
- BEHAVIORAL Sub-Study Mailed FIT Active Comparator Plain Envelope - Age Group 45-49
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,318 participants |
| Start Date | 2020-07-07 |
| Est. Completion | 2024-09-02 |
| Phase | NA |
What the finished NCT04406714 record still lists
NCT04406714 is an interventional study that assigns participants to a tested intervention. Its 4,318 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (208% higher).
The record links to 0 conditions, and to 3 interventions - of which Trial Mailed FIT Intervention - Age Group 50-75 is the first listed.
NCT04406714 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04406714 about?
NCT04406714 is a clinical study titled "Scaling CRC Screening Through Outreach, Referral, and Engagement (SCORE)". This study will test the effectiveness of mailing fecal immunochemical tests (FITs) in increasing colorectal cancer (CRC) screening rates in U.S. adults ages 45-75. We are implementing this study in two age groups, 45-49 years and 50-75 years.
What is the current status of trial NCT04406714?
This trial is currently completed. It is a NA study. The enrollment target is 4,318 participants. The study started on 2020-07-07. Estimated completion is 2024-09-02.
What interventions are being tested in trial NCT04406714?
The interventions under investigation include: Trial Mailed FIT Intervention - Age Group 50-75 (BEHAVIORAL), Sub-Study Mailed FIT Intervention Enhanced Envelope - Age Group 45-49 (BEHAVIORAL), Sub-Study Mailed FIT Active Comparator Plain Envelope - Age Group 45-49 (BEHAVIORAL).
Who is sponsoring clinical trial NCT04406714?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04406714's enrollment target sits among peer trials
4,318 30th of 2000 higher than 1,971 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05774951 · 4,300 participants · Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
- NCT05543616 · 4,292 participants · Phase 2
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
- NCT05910567 · 4,346 participants · NA
A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma
- NCT07044297 · 4,390 participants · Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI